Project Grant R35GM158421

Award Date 7/1/25
Completion Date 6/30/30
Dollars Obligated $386K
Federal Grant Program
93.859
Assistance Type
Project Grant
Place of Performance
Atlanta, GA 30332, USA
Similar Awards
This $509,982 Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) supports research to unravel the fundamental mechanisms governing cell-cell communication that underlie tissue pattern formation in animal development. The key research objectives are to investigate the role of specialized actin-based membrane protrusions called cytonemes in facilitating polarized exchange of the fibroblast growth...
This federal Project Grant award from the National Institute of General Medical Sciences (NIGMS), Biomedical Research and Research Training Program (CFDA 93.859), provides $1,683,145.00 to the University of Chicago to investigate the mechanisms governing the self-organization and interactions of diverse actin cytoskeleton networks in cells. The research aims to determine how cells allocate actin monomers between competing actin filament networks to control network size and density, as well as...
This $393,093 Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) will support research to uncover the interaction between gene expression, cell morphology, and tissue-level mechanics in embryonic development. The principal investigator, Bianca Dumitrascu, will leverage an integrative statistical machine learning framework to analyze 4D data on mammalian development across multiple species,...
This federal Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) provides $534,160 to support research on the molecular mechanisms underlying protein function. The key focus areas include: Elucidating the mechanisms by which ion transport proteins, such as TMEM175, CLC, IP3Rs, and CLN7, recognize and transport ions across cellular membranes, as well as how their activities are regulated. Investigating...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training Program (CFDA 93.859) provides $1,192,487 to the Rector & Visitors of the University of Virginia (UVA) to investigate the cellular and molecular mechanisms that govern effective tissue regeneration. The research program aims to uncover the genes and gene regulatory networks that regulate key phases of regeneration, including blastema formation,...
This $1,545,538 federal Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) supports research to understand the composition, assembly, and function of specialized chromatin domains. The research aims to uncover mechanisms controlling the establishment, spreading, and epigenetic inheritance of H3K27me3 histone modifications, as well as the role of ISWI chromatin remodeling enzymes in the assembly and...
This federal Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training Program (CFDA 93.859) provides $421,999.00 to Emory University to investigate how posttranscriptional mechanisms, such as local RNA regulation, instruct centrosome activity and function. The overarching goal is to better understand the cell cycle-dependent changes in RNA enrichment at centrosomes and the conserved regulatory paradigms that govern...
This is a Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training Program (CFDA 93.859). The total award is $387,500.00 and runs from May 1, 2025 to February 28, 2030. The grant supports research to understand the roles and functions of microRNAs, which are essential post-transcriptional regulators of gene expression, in animal development. The research program systematically investigates the functions of highly...
This is a Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859). The $422,173 award will support research at the University of Massachusetts Boston to investigate cellular signaling networks that control organ growth and tissue patterning during development. The research will focus on three key signaling pathways: the RTK/ERK pathway, Hippo signaling, and the Minibrain/Dyrk1a kinase network....
This federal Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) provides $966,000.00 in funding to New York University (NYU) from July 5, 2024 to May 31, 2028. The award supports research to elucidate the regulatory mechanisms that enable the evolutionarily conserved transcription factor Brachyury to control the precise temporal expression of genes required for notochord development in chordates. The...

This federal Project Grant award of $386,128 from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) will fund research to investigate fundamental mechanisms regulating cellular processes like fusion, survival, quiescence, and growth in the non-vertebrate chordate Ciona. The research aims to leverage Ciona's unique biphasic life cycle, which involves dramatic remodeling during metamorphosis, to identify additional genes regulating cell-cell fusion and further understand the structure-function of the fusogenic factor Myomaker at the subcellular level. The research will also explore how discrete stem cell compartments are protected and patterned during development despite differentiation and cell death around them, focusing on the role of the FGF/MAPK pathway in this process. The award, effective from July 1, 2025 to June 30, 2030, will be performed by the Georgia Tech Research Corporation.

Generated 6/24/25, 5:55 AM